Patent Assignment
Reel/Frame 045885/0921
Assignment of Assignor's Interest
Recorded: 2018-05-23
Pages: 4
Assignor
NOVARTIS PHARMA AG
Executed: 2015-07-31
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property
(1)
Selective Reduction of Cysteine Residues in Il-17 Antibodies
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 2018
From: HEITZMANN, MARKUS
To: NOVARTIS PHARMA AG
Reel/Frame 045885/0808 →
Assignment of Assignor's Interest
May 23, 2018
From: WINKLER, JOHANN
To: SANDOZ GMBH
Reel/Frame 045886/0023 →
Assignment of Assignor's Interest
May 23, 2018
From: SANDOZ GMBH
To: SANDOZ AG
Reel/Frame 045886/0226 →
Assignment of Assignor's Interest
May 23, 2018
From: SANDOZ AG
To: NOVARTIS AG
Reel/Frame 045886/0320 →
Assignment of Assignor's Interest
Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →